Free freight over $200 CAD 1 business day dispatch 99%+ purity specification Third-party HPLC and purity testing Held and shipped in Canada Save up to 35% at 10+ vials Free freight over $200 CAD 1 business day dispatch 99%+ purity specification Third-party HPLC and purity testing Held and shipped in Canada Save up to 35% at 10+ vials
Tier pricing Browse catalogue →
Bulk Peptides logo
[email protected]
Peptide Disulfide Bonds: Pairing, Scrambling and How to Confirm Them

Peptide Disulfide Bonds: Pairing, Scrambling and How to Confirm Them

For a sequence with cysteines in it, the residue order is only half of the structure. The other half is which sulfur atoms are bonded to which. Peptide disulfide bonds lock a chain into a loop or a folded shape, and getting them right is often the hardest step in making the molecule. Getting them wrong produces a product with the correct formula, the correct mass and the wrong structure. For QC and procurement staff comparing lots of a cysteine-containing peptide, it helps to understand how these bridges form, how they rearrange, and which tests can actually confirm them.

The chemistry in one paragraph

Cysteine carries a thiol (–SH) group. When two thiols are oxidised together they lose two hydrogen atoms and join as a disulfide (–S–S–). The bond can link two cysteines on the same chain, closing a ring, or two cysteines on different chains, joining molecules together. Each disulfide formed lowers the mass by about 2.016 Da compared with the fully reduced form. That small shift is useful: a mass spectrum can tell you how many bridges have formed. It cannot tell you where they are.

How many ways can the cysteines pair?

With two cysteines there is only one possible intramolecular bridge. Add more and the options multiply quickly:

Cysteines in the sequenceDisulfides formedPossible pairing patterns
211
423
6315
84105

Every one of those patterns has the same molecular formula. Only one is usually the intended structure. The rest are isomers that differ in shape, and often in how they behave in an assay, while looking identical by intact mass.

Forming peptide disulfide bonds during synthesis

Cysteine thiols are protected while the chain is assembled on the resin, so no bridges form during synthesis. Our article on the solid-phase synthesis cycle covers that stage. After cleavage, chemists choose one of two broad strategies.

Let the molecule choose

For a single disulfide, or where the native fold strongly favours one pattern, the reduced peptide is oxidised in dilute solution. Common approaches include simple air oxidation at mildly alkaline pH, oxidation assisted by DMSO, and redox buffers containing reduced and oxidised glutathione, which allow wrong pairings to break and reform until the most stable arrangement dominates. Dilution is essential. At high concentration, cysteines on neighbouring molecules find each other and form dimers and oligomers.

Direct each bridge

Where several disulfides must form in a defined pattern, cysteines are protected in pairs with different protecting groups that can be removed under different conditions. One pair is released and closed, then the next, so each bridge can form only where it is intended. This route is slower and costlier, and it is the reliable way to reach a specific connectivity in a multi-bridge peptide.

Scrambling after the fact

Disulfides are not permanently fixed. A free thiol, especially in its deprotonated thiolate form, can attack an existing disulfide and swap partners. This thiol-disulfide exchange lets a correctly folded peptide drift towards other isomers over time. Conditions that encourage it include:

  • alkaline pH, which increases the proportion of reactive thiolate;
  • any residual free cysteine, whether from incomplete oxidation or from partial reduction;
  • reducing agents such as DTT or TCEP, which break bridges outright;
  • warmth and long storage in solution.

Dry lyophilised material is far less prone to exchange than a solution. For analytical samples of disulfide-bonded peptides, a mildly acidic solvent, cold storage and short holding times all help, and reducing agents should be kept well away unless reduction is the point of the experiment. Our overview of light, oxygen and temperature covers the related degradation routes.

What each test actually confirms

MethodWhat it showsWhat it does not show
Intact massNumber of bridges formed (via the −2 Da per bond shift)Which cysteines are paired
Reduced vs non-reduced massThat bridges are present and break as expectedConnectivity
Ellman’s assayAmount of remaining free thiolWhich cysteines paired
Reversed-phase HPLCWhether more than one isomer is present, often as separate peaksWhich peak is which without a reference
Non-reduced peptide mapping by LC-MSWhich segments are joined, from linked fragment massesNothing routine; it needs a method built for each sequence

Peptide mapping under non-reducing conditions is the standard way to settle the question. The molecule is cut with a protease at sites between the cysteines, and any two fragments still linked through sulfur show up together, at the sum of their masses. Standard identity-and-purity certificates report intact mass and HPLC area, which confirms the formula and the bridge count but not the pairing.

Buying cysteine peptides by the lot

When the same disulfide-containing peptide is bought repeatedly, a few steps make lot comparisons meaningful:

  1. State the intended connectivity in your specification, for example Cys2–Cys7, not just the sequence.
  2. Compare the main-peak retention time and peak shape of each new lot against your first accepted lot under the same method. A new shoulder or split peak can signal a mispaired isomer.
  3. Check that the reported mass reflects the oxidised form, about 2 Da lighter per bridge than the reduced sequence.
  4. Record the certificate, cap and crimp colour and any chromatographic notes against each lot in your inventory log.

Bulk Peptides products are sent to third-party labs for HPLC purity testing, and certificates for some products can be viewed on our certificates of analysis page. For ring structures formed without sulfur, see cyclic versus linear peptides.

Bulk Peptides compounds are supplied for in-vitro laboratory research and analysis only. They are not for use in humans or animals, and this article is not a guide to any such use.

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*

Legal Disclaimer

The products offered by Bulk Peptides are intended solely for research purposes. These products are not for human consumption, are not intended for medical use, and have not been approved by the FDA or Health Canada for any therapeutic or diagnostic purpose. Bulk Peptides makes no claims regarding the safety, efficacy, or intended use of these products outside of a controlled research environment. By purchasing our products, you agree to use them strictly for scientific research and in compliance with all local laws and regulations.

GLP-1 15mg research peptide vial - Bulk Peptides Canada
Wholesale enquiries

Tell us what your lab runs through in a year.

If your lab reorders the same few compounds every quarter, send us the list and the volume and we will come back with a custom quote and a delivery schedule that fits your study calendar, usually inside one business day.

Request bulk pricing → Browse 42 products No account needed to see tier pricing. Every price on this site is already the price you pay.
0
    0
    Your Cart
    Your cart is empty